|
|
|
|
| LEADER |
03858nma a2200865 u 4500 |
| 001 |
EB002131909 |
| 003 |
EBX01000000000000001269966 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
221110 ||| eng |
| 020 |
|
|
|a 9783036546001
|
| 020 |
|
|
|a 9783036545998
|
| 020 |
|
|
|a books978-3-0365-4600-1
|
| 100 |
1 |
|
|a Bondarenko, Olesja
|
| 245 |
0 |
0 |
|a Nanoparticle-Macrophage Interactions
|h Elektronische Ressource
|b Implications for Nanosafety and Nanomedicine
|
| 260 |
|
|
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2022
|
| 300 |
|
|
|a 1 electronic resource (208 p.)
|
| 653 |
|
|
|a ICP-MS analysis of cell bound SiO2
|
| 653 |
|
|
|a macrophage
|
| 653 |
|
|
|a in vitro testing
|
| 653 |
|
|
|a anti-inflammatory
|
| 653 |
|
|
|a inflammation
|
| 653 |
|
|
|a gold nanoparticles
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a protein corona
|
| 653 |
|
|
|a Caco-2 cells
|
| 653 |
|
|
|a oral administration
|
| 653 |
|
|
|a monocytes
|
| 653 |
|
|
|a bovine serum albumin
|
| 653 |
|
|
|a nanomaterial
|
| 653 |
|
|
|a cell uptake
|
| 653 |
|
|
|a wound healing
|
| 653 |
|
|
|a 2D cultures
|
| 653 |
|
|
|a zebrafish
|
| 653 |
|
|
|a rifabutin
|
| 653 |
|
|
|a device
|
| 653 |
|
|
|a innate memory
|
| 653 |
|
|
|a carbon nanotube
|
| 653 |
|
|
|a synthetic amorphous silica
|
| 653 |
|
|
|a phagocytosis
|
| 653 |
|
|
|a in vitro models
|
| 653 |
|
|
|a class A type 1 scavenger receptors
|
| 653 |
|
|
|a nanostructured lipid carriers
|
| 653 |
|
|
|a nanomaterials
|
| 653 |
|
|
|a nanoparticle
|
| 653 |
|
|
|a macrophages
|
| 653 |
|
|
|a osteoarthritis
|
| 653 |
|
|
|a NR8383 alveolar macrophage
|
| 653 |
|
|
|a Crohn's disease
|
| 653 |
|
|
|a transcriptomics
|
| 653 |
|
|
|a nanoparticles
|
| 653 |
|
|
|a foot ulcer
|
| 653 |
|
|
|a cytotoxicity
|
| 653 |
|
|
|a chronic wound
|
| 653 |
|
|
|a chemokines
|
| 653 |
|
|
|a drug delivery
|
| 653 |
|
|
|a immune system
|
| 653 |
|
|
|a macrophage-nanoparticle interaction
|
| 653 |
|
|
|a 3D cultures
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a multi-walled carbon nanotubes
|
| 653 |
|
|
|a innate immunity
|
| 653 |
|
|
|a scavenger receptor
|
| 700 |
1 |
|
|a Torres Andón, Fernando
|
| 700 |
1 |
|
|a Bondarenko, Olesja
|
| 700 |
1 |
|
|a Torres Andón, Fernando
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 024 |
8 |
|
|a 10.3390/books978-3-0365-4600-1
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/6070
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/93174
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 700
|
| 520 |
|
|
|a Nanoparticles (NPs) offer unique properties for biomedical applications, leading to new nanomedicines. Recent examples of advanced nanoparticle-based nanomedicines are COVID-19 RNA vaccines. Regardless of the delivery route of the NPs into the body (intravenous or subcutaneous injection, oral, intranasal, etc.), NPs inevitably come into contact with immune cells, such as macrophages. Macrophages are phagocytizing cells that determine the fate and the lifetime of NPs in relevant biological fluids or tissues, which has consequences for both nanosafety and nanomedicine. The aim of this Special Issue is to cover recent advancements in our understanding of NP-macrophage interactions, with a focus on in vitro models for nanosafety and novel nanomedicine approaches that allow the modulation of the immunological profile of macrophages. The current Special Issue compiles nine papers: seven research articles and two review articles. The original articles include studies on the interaction of different nanomaterials, such as multi-walled carbon nanotubes (MWCNTs), amorphous silica, gold nanoparticles, lipid carriers, and microspheres, with macrophages in different scenarios.
|